Measurable residual disease (MRD)-testing in haematological cancers: A giant leap forward or sideways? (vol 68, 101226, 2024)BLOOD REVIEWSIF5.72024-11-010PRE
Measurable residual disease (MRD)-testing in haematological cancers: A giant leap forward or sideways?BLOOD REVIEWSIF5.72024-11-011OAAI
Are haematopoietic stem cell transplants stem cell transplants, is there a threshold dose of CD34-positive cells and how many are needed for rapid posttransplant granulocyte recovery? (vol 37, pg 1963, 2023)LEUKEMIAIF13.42023-08-300OAAI
Are haematopoietic stem cell transplants stem cell transplants, is there a threshold dose of CD34-positive cells and how many are needed for rapid posttransplant granulocyte recovery?LEUKEMIAIF13.42023-07-205OAAI
The Composite Immune Risk Score predicts overall survival after allogeneic hematopoietic stem cell transplantation: A retrospective analysis of 1838 casesAMERICAN JOURNAL OF HEMATOLOGYIF9.92023-01-023OAAI
Dynamic forecasting of severe acute graft-versus- host disease after transplantation (vol 2, pg 153, 2022)NATURE COMPUTATIONAL SCIENCEIF18.32022-05-030OAAI
Dynamic forecasting of severe acute graft-versus-host disease after transplantationNATURE COMPUTATIONAL SCIENCEIF18.32022-03-289OAAI
Short Stature in Patients with Diamond-Blackfan Anemia: A Cross-Sectional StudyJOURNAL OF PEDIATRICSIF3.52022-01-019PRE